Benefit | Strongest Product Associations and # of Responses |
Miconazole efficacy | M1: 983 (41%), M3: 1994 (41%), M7: 2940 (46%) Total: 5917 (43%) |
4 x faster relief | M1: 761 (32%), M3: 1545 (31%), M7: 1641 (26%), Tio1: 2556 (45%) Total: 6503 (34%) |
Safer vs. oral Rx | M1: 324 (13%), M3: 1145 (23%), M7: 1721 (27%), Tio1: 1631 (29%) Total: 4821 (25%) |
Patient prefers less mess ovule | M1: 1049 (44%), M3: 1276 (26%) Total: 2325 (32%) |
Women on OCs & oral anti-diabetics + other drugs | M1: 450 (19%), M3: 851 (17%), M7: 617 (10%), Tio1: 1467 (26%) Total: 3385 (18%) |
Resistance of oral fluconazole increasing | M1: 380 (16%), M3: 654 (13%), M7: 681 (11%), Tio1: 797 (14%) Total: 2512 (13%) |
Patient failed on fluconazole | M1: 477 (20%), M3: 507 (10%), M7: 828 (13%), Tio1: 728 (13%) Total: 2540 (13%) |
Preferred longer duration | M7: 3618 (57%) |
Safe in pregnancy | M7: 3025 (47%) |